annual CFO:
-$3.00B+$114.00M(+3.66%)Summary
- As of today (May 21, 2025), MRNA annual cash flow from operations is -$3.00 billion, with the most recent change of +$114.00 million (+3.66%) on December 31, 2024.
- During the last 3 years, MRNA annual CFO has fallen by -$16.62 billion (-122.06%).
- MRNA annual CFO is now -122.06% below its all-time high of $13.62 billion, reached on December 31, 2021.
Performance
MRNA Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$1.04B-$1.86B(-225.70%)Summary
- As of today (May 21, 2025), MRNA quarterly cash flow from operations is -$1.04 billion, with the most recent change of -$1.86 billion (-225.70%) on March 31, 2025.
- Over the past year, MRNA quarterly CFO has dropped by -$48.00 million (-4.85%).
- MRNA quarterly CFO is now -125.52% below its all-time high of $4.06 billion, reached on June 30, 2021.
Performance
MRNA quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$3.05B-$48.00M(-1.60%)Summary
- As of today (May 21, 2025), MRNA TTM cash flow from operations is -$3.05 billion, with the most recent change of -$48.00 million (-1.60%) on March 31, 2025.
- Over the past year, MRNA TTM CFO has dropped by -$170.00 million (-5.90%).
- MRNA TTM CFO is now -122.41% below its all-time high of $13.62 billion, reached on December 31, 2021.
Performance
MRNA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MRNA Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.7% | -4.8% | -5.9% |
| 3 y3 years | -122.1% | -137.5% | -122.8% |
| 5 y5 years | -554.5% | -878.3% | -625.4% |
MRNA Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -122.1% | +3.7% | -137.5% | +35.2% | -122.8% | +5.8% |
| 5 y | 5-year | -122.1% | +3.7% | -125.5% | +35.2% | -122.4% | +5.8% |
| alltime | all time | -122.1% | +3.7% | -125.5% | +35.2% | -122.4% | +5.8% |
MRNA Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$1.04B(-225.7%) | -$3.05B(+1.6%) |
| Dec 2024 | -$3.00B(-3.7%) | $825.00M(-152.7%) | -$3.00B(-6.3%) |
| Sep 2024 | - | -$1.57B(+22.9%) | -$3.21B(-1.0%) |
| Jun 2024 | - | -$1.27B(+28.8%) | -$3.24B(+12.5%) |
| Mar 2024 | - | -$989.00M(-259.0%) | -$2.88B(-7.6%) |
| Dec 2023 | -$3.12B(-162.6%) | $622.00M(-138.9%) | -$3.12B(+50.0%) |
| Sep 2023 | - | -$1.60B(+74.9%) | -$2.08B(+819.5%) |
| Jun 2023 | - | -$915.00M(-25.3%) | -$226.00M(-122.8%) |
| Mar 2023 | - | -$1.23B(-173.7%) | $993.00M(-80.1%) |
| Dec 2022 | $4.98B(-63.4%) | $1.66B(+559.5%) | $4.98B(-24.9%) |
| Sep 2022 | - | $252.00M(-17.1%) | $6.63B(-31.3%) |
| Jun 2022 | - | $304.00M(-89.0%) | $9.65B(-28.0%) |
| Mar 2022 | - | $2.76B(-16.5%) | $13.41B(-1.5%) |
| Dec 2021 | $13.62B(+571.9%) | $3.31B(+1.0%) | $13.62B(+17.7%) |
| Sep 2021 | - | $3.28B(-19.4%) | $11.57B(+25.9%) |
| Jun 2021 | - | $4.06B(+36.8%) | $9.19B(+80.1%) |
| Mar 2021 | - | $2.97B(+135.0%) | $5.10B(+151.8%) |
| Dec 2020 | $2.03B(-541.6%) | $1.26B(+41.5%) | $2.03B(+205.3%) |
| Sep 2020 | - | $893.00M(-3820.8%) | $663.95M(-297.5%) |
| Jun 2020 | - | -$24.00M(-77.4%) | -$336.15M(-20.1%) |
| Mar 2020 | - | -$106.00M(+7.0%) | -$420.73M(-8.3%) |
| Dec 2019 | -$459.00M(+38.7%) | -$99.05M(-7.5%) | -$459.00M(+1.8%) |
| Sep 2019 | - | -$107.09M(-1.4%) | -$450.97M(+6.3%) |
| Jun 2019 | - | -$108.58M(-24.7%) | -$424.08M(+16.6%) |
| Mar 2019 | - | -$144.27M(+58.5%) | -$363.75M(+9.9%) |
| Dec 2018 | -$330.87M(-0.2%) | -$91.02M(+13.5%) | -$330.87M(+37.8%) |
| Sep 2018 | - | -$80.21M(+66.2%) | -$240.18M(+50.0%) |
| Jun 2018 | - | -$48.25M(-56.7%) | -$160.16M(+42.6%) |
| Mar 2018 | - | -$111.39M(>+9900.0%) | -$112.28M(+8806.3%) |
| Dec 2017 | -$331.48M(-596.7%) | -$337.50K(+77.0%) | -$1.26M(+9.7%) |
| Sep 2017 | - | -$190.70K(-48.2%) | -$1.15M(+15.5%) |
| Jun 2017 | - | -$368.50K(+1.2%) | -$995.30K(+40.9%) |
| Mar 2017 | - | -$364.00K(+60.9%) | -$706.50K(+35.2%) |
| Dec 2016 | $66.73M(-3182.4%) | - | - |
| Dec 2016 | - | -$226.20K(+518.0%) | -$522.40K(-38.8%) |
| Sep 2016 | - | -$36.60K(-54.1%) | -$854.20K(-35.6%) |
| Jun 2016 | - | -$79.70K(-55.7%) | -$1.33M(-21.2%) |
| Mar 2016 | - | -$179.90K(-67.8%) | -$1.68M(-22.3%) |
| Dec 2015 | -$2.17M(-54.7%) | -$558.00K(+9.8%) | -$2.17M(-28.0%) |
| Sep 2015 | - | -$508.00K(+16.2%) | -$3.01M(-16.7%) |
| Jun 2015 | - | -$437.00K(-34.0%) | -$3.61M(-17.5%) |
| Mar 2015 | - | -$662.00K(-52.8%) | -$4.38M(-8.4%) |
| Dec 2014 | -$4.78M(-1776.8%) | -$1.40M(+26.2%) | -$4.78M(+63.8%) |
| Sep 2014 | - | -$1.11M(-7.5%) | -$2.92M(+85.4%) |
| Jun 2014 | - | -$1.20M(+12.8%) | -$1.57M(+451.9%) |
| Mar 2014 | - | -$1.06M(-331.5%) | -$285.00K(-200.0%) |
| Dec 2013 | $285.00K(-106.5%) | $460.00K(+97.4%) | $285.00K(-133.9%) |
| Sep 2013 | - | $233.00K(+167.8%) | -$840.00K(-36.7%) |
| Jun 2013 | - | $87.00K(-117.6%) | -$1.33M(-22.4%) |
| Mar 2013 | - | -$495.00K(-25.6%) | -$1.71M(-61.1%) |
| Dec 2012 | -$4.39M(-72.8%) | -$665.00K(+162.8%) | -$4.39M(-22.3%) |
| Sep 2012 | - | -$253.00K(-14.2%) | -$5.65M(-44.4%) |
| Jun 2012 | - | -$295.00K(-90.7%) | -$10.16M(-31.3%) |
| Mar 2012 | - | -$3.18M(+65.3%) | -$14.79M(-8.3%) |
| Dec 2011 | -$16.12M(-4.1%) | -$1.92M(-59.7%) | -$16.12M(-5.3%) |
| Sep 2011 | - | -$4.76M(-3.2%) | -$17.02M(-1.5%) |
| Jun 2011 | - | -$4.92M(+9.1%) | -$17.29M(+2.3%) |
| Mar 2011 | - | -$4.51M(+59.4%) | -$16.90M(+0.6%) |
| Dec 2010 | -$16.80M(+123.3%) | -$2.83M(-43.8%) | -$16.80M(-5.1%) |
| Sep 2010 | - | -$5.03M(+11.1%) | -$17.70M(+1.7%) |
| Jun 2010 | - | -$4.53M(+2.7%) | -$17.40M(-9.0%) |
| Mar 2010 | - | -$4.41M(+18.3%) | -$19.12M(+154.0%) |
| Dec 2009 | -$7.53M | -$3.73M(-21.3%) | -$7.53M(-23.7%) |
| Sep 2009 | - | -$4.74M(-24.1%) | -$9.87M(-23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | -$6.24M(-186.9%) | -$12.91M(-24.7%) |
| Mar 2009 | - | $7.18M(-218.3%) | -$17.13M(-57.7%) |
| Dec 2008 | -$40.47M(-12.9%) | -$6.07M(-21.9%) | -$40.47M(-17.8%) |
| Sep 2008 | - | -$7.78M(-25.7%) | -$49.25M(-8.0%) |
| Jun 2008 | - | -$10.47M(-35.2%) | -$53.51M(-0.1%) |
| Mar 2008 | - | -$16.16M(+8.9%) | -$53.57M(+15.3%) |
| Dec 2007 | -$46.46M(+214.9%) | -$14.84M(+23.3%) | -$46.46M(+21.0%) |
| Sep 2007 | - | -$12.04M(+14.3%) | -$38.39M(+14.8%) |
| Jun 2007 | - | -$10.53M(+16.3%) | -$33.45M(+65.7%) |
| Mar 2007 | - | -$9.05M(+33.6%) | -$20.18M(+36.8%) |
| Dec 2006 | -$14.75M(-52.8%) | -$6.78M(-4.5%) | -$14.75M(-7.1%) |
| Sep 2006 | - | -$7.09M(-359.2%) | -$15.89M(-14.2%) |
| Jun 2006 | - | $2.74M(-175.6%) | -$18.52M(-35.3%) |
| Mar 2006 | - | -$3.62M(-54.2%) | -$28.61M(-8.5%) |
| Dec 2005 | -$31.28M(+63.2%) | -$7.91M(-18.6%) | -$31.28M(+42.1%) |
| Sep 2005 | - | -$9.72M(+32.3%) | -$22.02M(+18.7%) |
| Jun 2005 | - | -$7.35M(+16.7%) | -$18.55M(+6.3%) |
| Mar 2005 | - | -$6.30M(-565.3%) | -$17.46M(-8.9%) |
| Dec 2004 | -$19.17M(+149.4%) | $1.35M(-121.6%) | -$19.17M(-28.3%) |
| Sep 2004 | - | -$6.26M(+0.1%) | -$26.71M(+1.1%) |
| Jun 2004 | - | -$6.26M(-21.8%) | -$26.42M(+7.0%) |
| Mar 2004 | - | -$8.01M(+29.2%) | -$24.70M(+221.3%) |
| Dec 2003 | -$7.69M(+18.2%) | -$6.19M(+3.8%) | -$7.69M(+24.1%) |
| Sep 2003 | - | -$5.97M(+31.7%) | -$6.19M(+108.9%) |
| Jun 2003 | - | -$4.53M(-150.3%) | -$2.96M(-206.9%) |
| Mar 2003 | - | $9.01M(-291.6%) | $2.77M(-142.7%) |
| Dec 2002 | -$6.50M(-11.7%) | -$4.70M(+71.7%) | -$6.50M(+31.1%) |
| Sep 2002 | - | -$2.74M(-326.7%) | -$4.96M(+64.8%) |
| Jun 2002 | - | $1.21M(-545.8%) | -$3.01M(-50.7%) |
| Mar 2002 | - | -$271.00K(-91.4%) | -$6.11M(-17.1%) |
| Dec 2001 | -$7.37M(-6.3%) | -$3.16M(+300.3%) | -$7.37M(+27.0%) |
| Sep 2001 | - | -$789.00K(-58.3%) | -$5.80M(-14.9%) |
| Jun 2001 | - | -$1.89M(+23.7%) | -$6.81M(+16.9%) |
| Mar 2001 | - | -$1.53M(-3.8%) | -$5.83M(-25.9%) |
| Dec 2000 | -$7.86M(+48.3%) | -$1.59M(-11.8%) | -$7.86M(-3.8%) |
| Sep 2000 | - | -$1.80M(+99.1%) | -$8.17M(+10.9%) |
| Jun 2000 | - | -$905.00K(-74.6%) | -$7.37M(-6.3%) |
| Mar 2000 | - | -$3.56M(+87.6%) | -$7.87M(+48.4%) |
| Dec 1999 | -$5.30M(+103.8%) | -$1.90M(+90.0%) | -$5.30M(+29.3%) |
| Sep 1999 | - | -$1.00M(-28.6%) | -$4.10M(+32.3%) |
| Jun 1999 | - | -$1.40M(+40.0%) | -$3.10M(+55.0%) |
| Mar 1999 | - | -$1.00M(+42.9%) | -$2.00M(-23.1%) |
| Dec 1998 | -$2.60M(-18.8%) | -$700.00K(<-9900.0%) | -$2.60M(-3.7%) |
| Sep 1998 | - | $0.00(-100.0%) | -$2.70M(-28.9%) |
| Jun 1998 | - | -$300.00K(-81.3%) | -$3.80M(-13.6%) |
| Mar 1998 | - | -$1.60M(+100.0%) | -$4.40M(+37.5%) |
| Dec 1997 | -$3.20M(+540.0%) | -$800.00K(-27.3%) | -$3.20M(+33.3%) |
| Sep 1997 | - | -$1.10M(+22.2%) | -$2.40M(+33.3%) |
| Jun 1997 | - | -$900.00K(+125.0%) | -$1.80M(+200.0%) |
| Mar 1997 | - | -$400.00K(-20.0%) | -$600.00K(+20.0%) |
| Dec 1996 | -$500.00K(-600.0%) | - | - |
| Sep 1996 | - | -$500.00K(-266.7%) | -$500.00K(-600.0%) |
| Jun 1996 | $100.00K(0.0%) | $300.00K(-400.0%) | $100.00K(-150.0%) |
| Mar 1996 | - | -$100.00K(-50.0%) | -$200.00K(+100.0%) |
| Dec 1995 | - | -$200.00K(-300.0%) | -$100.00K(-200.0%) |
| Sep 1995 | - | $100.00K(>+9900.0%) | $100.00K(0.0%) |
| Jun 1995 | $100.00K(0.0%) | $0.00(0.0%) | $100.00K(0.0%) |
| Mar 1995 | - | $0.00(0.0%) | $100.00K(-200.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$100.00K(-200.0%) |
| Sep 1994 | - | $100.00K(>+9900.0%) | $100.00K(0.0%) |
| Jun 1994 | $100.00K | $0.00(-100.0%) | $100.00K(0.0%) |
| Mar 1994 | - | -$200.00K(-200.0%) | $100.00K(-66.7%) |
| Dec 1993 | - | $200.00K(+100.0%) | $300.00K(+200.0%) |
| Sep 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna annual cash flow from operations?
- What is the all time high annual CFO for Moderna?
- What is Moderna annual CFO year-on-year change?
- What is Moderna quarterly cash flow from operations?
- What is the all time high quarterly CFO for Moderna?
- What is Moderna quarterly CFO year-on-year change?
- What is Moderna TTM cash flow from operations?
- What is the all time high TTM CFO for Moderna?
- What is Moderna TTM CFO year-on-year change?
What is Moderna annual cash flow from operations?
The current annual CFO of MRNA is -$3.00B
What is the all time high annual CFO for Moderna?
Moderna all-time high annual cash flow from operations is $13.62B
What is Moderna annual CFO year-on-year change?
Over the past year, MRNA annual cash flow from operations has changed by +$114.00M (+3.66%)
What is Moderna quarterly cash flow from operations?
The current quarterly CFO of MRNA is -$1.04B
What is the all time high quarterly CFO for Moderna?
Moderna all-time high quarterly cash flow from operations is $4.06B
What is Moderna quarterly CFO year-on-year change?
Over the past year, MRNA quarterly cash flow from operations has changed by -$48.00M (-4.85%)
What is Moderna TTM cash flow from operations?
The current TTM CFO of MRNA is -$3.05B
What is the all time high TTM CFO for Moderna?
Moderna all-time high TTM cash flow from operations is $13.62B
What is Moderna TTM CFO year-on-year change?
Over the past year, MRNA TTM cash flow from operations has changed by -$170.00M (-5.90%)